95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.27%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.18%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.08%
Negative EBIT growth while FNV is at 117.95%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.08%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-2.61%
Negative net income growth while FNV stands at 114.31%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.26%
Negative EPS growth while FNV is at 114.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.26%
Negative diluted EPS growth while FNV is at 114.29%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.02%
Share count expansion well above FNV's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.01%
Diluted share reduction more than 1.5x FNV's 0.12%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-11.81%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-9.47%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
40.93%
10Y revenue/share CAGR under 50% of FNV's 86.86%. Michael Burry would suspect a lasting competitive disadvantage.
28.77%
5Y revenue/share CAGR at 75-90% of FNV's 37.44%. Bill Ackman would encourage strategies to match competitor’s pace.
-9.56%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
50.50%
10Y OCF/share CAGR under 50% of FNV's 113.04%. Michael Burry would worry about a persistent underperformance in cash creation.
81.81%
5Y OCF/share CAGR above 1.5x FNV's 19.87%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-6.37%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
62.13%
Below 50% of FNV's 211.07%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
180.54%
5Y net income/share CAGR above 1.5x FNV's 114.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
0.46%
Positive short-term CAGR while FNV is negative. John Neff would see a clear advantage in near-term profit trajectory.
62.55%
10Y equity/share CAGR 1.25-1.5x FNV's 49.04%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
32.72%
5Y equity/share CAGR above 1.5x FNV's 19.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.48%
3Y equity/share CAGR above 1.5x FNV's 2.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-48.46%
Firm’s AR is declining while FNV shows 14.14%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while FNV stands at 924.19%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.54%
Asset growth above 1.5x FNV's 1.50%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.74%
1.25-1.5x FNV's 1.30%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-4.23%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-28.25%
We cut SG&A while FNV invests at 58.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.